| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Wai Conrad | CEO, Counterpart Health | C/O CLOVER HEALTH INVESTMENTS, CORP., NOT APPLICABLE, WILMINGTON | /s/ Peter J. Rivas as attorney-in-fact for Conrad Wai | 17 Jun 2025 | 0001971702 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CLOV | Class A Common Stock | Tax liability | $284,408 | -98,411 | -3% | $2.89 | 3,138,535 | 14 Jun 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. |